↓ Skip to main content

Dove Medical Press

Article Metrics

Refractory Sarcoidosis: A Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
66 Mendeley
Title
<p>Refractory Sarcoidosis: A Review</p>
Published in
Therapeutics and Clinical Risk Management, April 2020
DOI 10.2147/tcrm.s192922
Pubmed ID
Authors

Thomas El Jammal, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Dominique Valeyre, Pascal Sève

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 15%
Student > Master 9 14%
Student > Ph. D. Student 6 9%
Researcher 5 8%
Student > Doctoral Student 4 6%
Other 15 23%
Unknown 17 26%
Readers by discipline Count As %
Medicine and Dentistry 23 35%
Nursing and Health Professions 4 6%
Neuroscience 3 5%
Business, Management and Accounting 2 3%
Social Sciences 2 3%
Other 11 17%
Unknown 21 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2020.
All research outputs
#10,525,545
of 18,455,180 outputs
Outputs from Therapeutics and Clinical Risk Management
#513
of 1,137 outputs
Outputs of similar age
#149,833
of 304,281 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 1 outputs
Altmetric has tracked 18,455,180 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,137 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,281 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them